Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume 30, Issue 13, Pages 1728-1738
Publisher
Wiley
Online
2015-07-24
DOI
10.1002/mds.26326
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study
- (2015) Per Svenningsson et al. BRAIN
- Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in rats
- (2014) D Lindenbach et al. BRITISH JOURNAL OF PHARMACOLOGY
- Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patients
- (2014) Marios Politis et al. JOURNAL OF CLINICAL INVESTIGATION
- Basal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia
- (2013) Golnasim Riahi et al. BIOCHEMICAL PHARMACOLOGY
- Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia
- (2013) Erwan Bezard et al. MOVEMENT DISORDERS
- The serotonergic system in motor and non-motor manifestations of Parkinson’s disease
- (2013) Philippe Huot et al. EXPERIMENTAL BRAIN RESEARCH
- Dopamine- and cAMP-regulated Phosphoprotein of 32-kDa (DARPP-32)-dependent Activation of Extracellular Signal-regulated Kinase (ERK) and Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in Experimental Parkinsonism
- (2012) Emanuela Santini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Serotonergic involvement in levodopa-induced dyskinesias in Parkinson’s disease
- (2012) Perdita A. Cheshire et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Nociceptin/Orphanin FQ Receptor Agonists Attenuate L-DOPA-Induced Dyskinesias
- (2012) M. Marti et al. JOURNAL OF NEUROSCIENCE
- Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats
- (2011) Kristin B. Dupre et al. EXPERIMENTAL NEUROLOGY
- Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels
- (2011) Simone Bido et al. JOURNAL OF NEUROCHEMISTRY
- Serotonergic modulation of receptor occupancy in rats treated with l-DOPA after unilateral 6-OHDA lesioning
- (2011) Adjmal Nahimi et al. JOURNAL OF NEUROCHEMISTRY
- In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to l-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels
- (2011) Flora Mela et al. NEUROBIOLOGY OF DISEASE
- Role of the primary motor cortex in l-DOPA-induced dyskinesia and its modulation by 5-HT1A receptor stimulation
- (2011) Corinne Y. Ostock et al. NEUROPHARMACOLOGY
- Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial
- (2011) Hideyuki Sawada et al. PLoS One
- The serotonergic system in Parkinson's disease
- (2011) Philippe Huot et al. PROGRESS IN NEUROBIOLOGY
- L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission
- (2011) Michael Feyder et al. Frontiers in Behavioral Neuroscience
- mTORC1 signaling in Parkinson disease and L-DOPA-induced dyskinesia: A sensitized matter
- (2010) Emanuela Santini et al. CELL CYCLE
- Serotonergic neurons mediate ectopic release of dopamine induced by l-DOPA in a rat model of Parkinson's disease
- (2010) Sylvia Navailles et al. NEUROBIOLOGY OF DISEASE
- Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1Areceptor agonist
- (2009) A Newman-Tancredi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model
- (2009) Ana Muñoz et al. EXPERIMENTAL NEUROLOGY
- l-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson’s disease: temporal and quantitative relationship to the expression of dyskinesia
- (2009) Hanna S. Lindgren et al. JOURNAL OF NEUROCHEMISTRY
- Serotonin 1B receptor stimulation reduces D1 receptor agonist-induced dyskinesia
- (2009) Karen L. Eskow Jaunarajs et al. NEUROREPORT
- Low doses of sarizotan reduce dyskinesias and maintain antiparkinsonian efficacy of l-Dopa in parkinsonian monkeys
- (2009) Laurent Grégoire et al. PARKINSONISM & RELATED DISORDERS
- Inhibition of mTOR Signaling in Parkinson's Disease Prevents L-DOPA-Induced Dyskinesia
- (2009) E. Santini et al. Science Signaling
- Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia
- (2008) A. Munoz et al. BRAIN
- l-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice
- (2008) Emanuela Santini et al. JOURNAL OF NEUROCHEMISTRY
- Placebo influences on dyskinesia in Parkinson's disease
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in L-DOPA treatment of an animal model of Parkinsonism
- (2008) X. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started